[Not Available].
作者信息
Novac Carmen, Radulian Gabriela, Orzan Anca, Balgradean Mihaela
机构信息
M. S. Curie" Children Emergency Hospital, Bucharest, Romania.
"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
出版信息
Maedica (Bucur). 2019 Mar;14(1):53-58. doi: 10.26574/maedica.2019.14.1.53.
Abstract
摘要
相似文献
1
[Not Available].
Maedica (Bucur). 2019 Mar;14(1):53-58. doi: 10.26574/maedica.2019.14.1.53.
引用本文的文献
1
C-Peptide Ameliorates Particulate Matter 2.5-Induced Skin Cell Apoptosis by Inhibiting NADPH Oxidation.
Biomol Ther (Seoul). 2025 Jan 1;33(1):221-230. doi: 10.4062/biomolther.2024.053. Epub 2024 Dec 18.
2
Future clinical prospects of C-peptide testing in the early diagnosis of gestational diabetes.
World J Exp Med. 2024 Mar 20;14(1):89320. doi: 10.5493/wjem.v14.i1.89320.
3
Association of Obesity Indices with Diabetic Kidney Disease and Diabetic Retinopathy in Type 2 Diabetes: A Real-World Study.
J Diabetes Res. 2023 Apr 15;2023:3819830. doi: 10.1155/2023/3819830. eCollection 2023.
本文引用的文献
1
C-peptide: new findings and therapeutic possibilities.
Diabetes Res Clin Pract. 2015 Mar;107(3):309-19. doi: 10.1016/j.diabres.2015.01.016. Epub 2015 Jan 21.
2
Physiological effects and therapeutic potential of proinsulin C-peptide.
Am J Physiol Endocrinol Metab. 2014 Dec 1;307(11):E955-68. doi: 10.1152/ajpendo.00130.2014. Epub 2014 Sep 23.
3
The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells.
Diabetologia. 2014 Jan;57(1):187-91. doi: 10.1007/s00125-013-3067-x.
4
Residual β-Cell function 3-6 years after onset of type 1 diabetes reduces risk of severe hypoglycemia in children and adolescents.
Diabetes Care. 2013 Nov;36(11):3454-9. doi: 10.2337/dc13-0418. Epub 2013 Aug 29.
5
Decline of C-peptide during the first year after diagnosis of Type 1 diabetes in children and adolescents.
Diabetes Res Clin Pract. 2013 May;100(2):203-9. doi: 10.1016/j.diabres.2013.03.003. Epub 2013 Mar 22.
6
The clinical utility of C-peptide measurement in the care of patients with diabetes.
Diabet Med. 2013 Jul;30(7):803-17. doi: 10.1111/dme.12159.
7
Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data.
Diabetes. 2012 Aug;61(8):2066-73. doi: 10.2337/db11-1538. Epub 2012 Jun 11.
8
The clinical potential of C-peptide replacement in type 1 diabetes.
Diabetes. 2012 Apr;61(4):761-72. doi: 10.2337/db11-1423.
9
C-peptide in the classification of diabetes in children and adolescents.
Pediatr Diabetes. 2012 Feb;13(1):45-50. doi: 10.1111/j.1399-5448.2011.00807.x. Epub 2011 Sep 13.
10
Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes.
Diabetes Care. 2011 Feb;34(2):286-91. doi: 10.2337/dc10-1293.
Zotero 插件